¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"È¿"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
minimal effective dose
ÃÖ¼ÒÀ¯È¿·®
malate dehydrogenase
¸»»êÅ»¼ö¼ÒÈ¿¼Ò
mucinase
Á¡¾×ºÐÇØÈ¿¼Ò
mucous fermentation
Á¡¾×¹ßÈ¿
myeloperoxidase
°ñ¼ö¼¼Æ÷Çü°ú»êÈÈ¿¼Ò, ¸¶ÀÌ¿¤·ÎÆÛ·Ï½Ãµ¥À̽º
myophosphorylase
±Ù(À°)ÀλêºÐÇØÈ¿¼Ò
masking effect
ÀºÆóÈ¿°ú
mass effect
µ¢ÀÌÈ¿°ú, Á¾±«È¿°ú
mean effective dose
Æò±ÕÀ¯È¿¼±·®
median effective dose
1. Áß°£À¯È¿¿ë·® 2. Áß°£À¯È¿¼±·®
mesomeric effect
°ø¸íÈ¿°ú
magnetic field effect
ÀÚÀåÈ¿°ú
magnetic moment nulling
ÀÚ±â¸ð¸àÆ®¹«È¿È
metalloenzyme
±Ý¼ÓÈ¿¼Ò
metalloproteinase
±Ý¼Ó´Ü¹éºÐÇØÈ¿¼Ò
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ferment
¹ßÈ¿¼Ò
fermentation
¹ßÈ¿
fermenter
¹ßÈ¿Åë
ferrochelatase
ö°áÇÕÈ¿¼Ò
fructokinase
°ú´çÈ¿¼Ò, ÇÁ·èÅäŰ³ª¾ÆÁ¦
ferment fever
¹ßÈ¿¼Ò¿
fermentation factor
¹ßÈ¿ÀÎÀÚ
fermentation fever
¹ßÈ¿¿
fermentation sugar
´ç¹ßÈ¿, ´çºÐÇØ
fermentation test
¹ßÈ¿½ÃÇè
fermentative organism
¹ßÈ¿±Õ
glucose fermenter
Æ÷µµ´ç¹ßÈ¿Åë
glycolytic ferment
ÇØ´ç¹ßÈ¿¼Ò, ´ç¿ëÇØ¹ßÈ¿¼Ò
inorganic ferment
¹«±â¹ßÈ¿¼Ò
intestinal fermentation
âÀÚ¼Ó¹ßÈ¿
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
inotropic effect
¼öÃàÃËÁøÈ¿°ú.
peroxidase
°ú»êÈÈ¿¼Ò
peroxidase label[l]ing
°ú»êÈÈ¿¼ÒÇ¥Áö
phase shift effect
À§»ó º¯À§ È¿°ú
phenylalanine hydroxylase
Æä´Ò¾Ë¶ó´ÑÈ÷µå·Ï½Ç·¹À̽º<--¼ö»êÈÈ¿¼Ò>
phenylalanine hydroxylase
Æä´Ò¾Ë¶ó´Ñ¼ö»êÈÈ¿¼Ò(¡ûùý£áÈ)
phosphatase
Æ÷½ºÆÄŸÁ¦, ÀλêÈ¿¼Ò(ìÝß« ý£áÈ).
phosphatase
ÀλêÈ¿¼Ò(×òß«ý£áÈ)
phosphate dehydrogenase deficiency
Àλ꿰ݼö¼ÒÈ¿¼Ò°áÇÌÁõ
phosphocreatinase
Æ÷½ºÆ÷Å©·¹¾ÆÆ¾ºÐÇØÈ¿¼Ò, Æ÷½ºÆ÷Å©·¹¾ÆÆ¼³ªÁ¦.
phosphogalaotse uridyl transferase
Æ÷½ºÆ÷°¥¶ôÅ佺¿ì¸®µôÆ®¶õ½ºÆÛ¶óÁ¦<--ÀüÀÌÈ¿¼Ò>
phosphoglucoisomerase
Æ÷½ºÆ÷Æ÷µµ´çÀ̼ºÈÈ¿¼Ò.
phosphoglucomutase
Æ÷½ºÆ÷±Û·çÄÚ¹«Å¸¾ÆÁ¦<ÀüÀ§È¿¼Ò>
phosphohexoisomerase
Æ÷½ºÆ÷Çí¼ÒÀ̼Ҹ޶óÁ¦<À̼ºÈÈ¿¼Ò>
phospholecithinase
Æ÷½ºÆ÷·¹½ÃƾºÐÇØÈ¿¼Ò.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
effect
È¿°ú, ÀÛ¿ë.
effect concentration(=activity)
À¯È¿³óµµ(êóüùÒØÓø)
effect, Pasteur
ÆÄ½ºÆ©¸£È¿°ú
effect, cytopathogenic
¼¼Æ÷º´º¯È¿°ú
effective TR
À¯È¿ ¹Ýº¹ ½Ã°£
effective alveolar air
À¯È¿ÆóÆ÷°ø±â(êóüùøËøàÍöѨ).
effective alveolar ventilation =EAV
À¯È¿ÆóÆ÷ȯ±â(·®)(êóüùøËøàüµÑ¨åÖ) .
effective blood volume
À¯È¿Ç÷¾×·®(êóüùúìäûÕá).
effective blood volume
À¯È¿Ç÷¾×·®.
effective capacity
À¯È¿¿ë·®.
effective charge
À¯È¿ÀüÇÏ(¡ï³ùÃ).
effective chlorine
À¯È¿¿°¼Ò.
effective circulating volume
À¯È¿¼øÈ¯¿ëÀû(êóüùâàü»é»îÝ)
effective current
À¯È¿Àü·ù.
effective demand
À¯È¿¼ö¿ä.
ÀÌÀü
´ÙÀ½
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
receptor destroying enzyme
¼ö¿ëü ÆÄ±«È¿¼Ò(áôé»ô÷÷òÎÕý£áÈ)
recombinase
"ÀçÁ¶ÇÕÈ¿¼Ò(î¢ðÚùêý£áÈ), ¸®ÄÞºñ³×À̽º"
reductase
"¸®´ÚÅ×À̽º, ȯ¿øÈ¿¼Ò(ü½êªý£áÈ)"
regulatory enzyme
Á¶Àý È¿¼Ò(ðàï½ý£áÈ)
relative plating efficiency
»ó´ë(ßÓÓß) ±ò±â È¿À²(üù×Ë)
relaxation effect
ÀÌ¿Ï È¿°ú(ì¬èÐüùÍý)
relaxing enzyme
ÀÌ¿Ï È¿¼Ò(ì¬èÐý£áÈ)
rennet enzyme
·»³Ý È¿¼Ò(ý£áÈ)
repair enzyme
¼öº¹ È¿¼Ò(ý£áÈ)
replicase
"¸®Çø®ÄÉÀ̽º, º¹Á¦È¿¼Ò(ÜÜð²ý£áÈ)"
repressible enzyme
¾ïÁ¦¼º È¿¼Ò(åäð¤àõý£áÈ)
respiratory enzyme
È£Èí È¿¼Ò(ý£áÈ)
respiratory enzyme complex
È£Èí È¿¼Ò º¹ÇÕü(ÜÜùêô÷)
restriction enzyme
Á¦ÇÑÈ¿¼Ò(ð¤ùÚý£áÈ)
Schardinger enzyme
»þ¸£µù°Å È¿¼Ò(ý£áÈ)
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
¼³¸í
sustained action drug
ÁöÈ¿¼º ¾àÁ¦
sustained release drug
ÁöÈ¿¼º ¾àÁ¦
synthetase
½ÅÅ×Å×À̽º, ½ÅÅןÁ¦, ÇÕ¼º È¿¼Ò
ATP ȤÀº ±×¿Í À¯»çÇÑ »ïÀλ꿰¿¡¼
T1 shortening effect
T1 ´ÜÃà È¿°ú
thermal efficiency
¿ È¿À²
¿ ±â°ü¿¡ ÀÇÇØ ¿ ¿¡³ÊÁö¸¦ ÀÏ·Î º¯È¯ÇÒ ¶§ ¾ò¾îÁø Àϰú ÁÖ¾îÁø ¿ ¿¡³ÊÁö¿ÍÀÇ ºñ.
thrombinogenase
Æ®·Òºó ¹ß»ý È¿¼Ò
topoisomerase
±¹¼Ò À̼ºÈ È¿¼Ò
total acid phosphatase
Ãѻ꼺 ÀÎ»ê ºÐÇØ È¿¼Ò, Ãѻ꼺 Æ÷½ºÆÄŸÁ¦
toxenzyme
µ¶¼º È¿¼Ò
training effect
ÈÆ·Ã È¿°ú
transaminase
¾Æ¹Ì³ë±â ÀüÀÌ È¿¼Ò
¾Æ¹Ì³ë»ê°ú ÄÉÅä»ê°úÀÇ »çÀÌ¿¡¼ ¾Æ¹Ì³ë±â¸¦ °¡¿ªÀûÀ¸·Î ÀüÀ̽ÃŰ´Â ¹ÝÀÀÀ» Ã˸ÅÇÏ´Â È¿¼Ò. Á¤½Ä ¸íĪÀº ¾Æ¹Ì³ë Æ®¶õ½ºÆä¶ó¾ÆÁ¦
Tyndall effect
Tyndall È¿°ú
ÀÛÀº ÄÝ·ÎÀ̵å ÀÔÀÚ´Â ´«¿¡ º¸ÀÌÁö ¾ÊÁö¸¸ ÀÔÀÚµéÀÌ ºûÀ» »ê¶õ½ÃŰ¹Ç·Î Á÷°¢ ¹æÇâ¿¡¼ °üÂûÇÏ¸é ºûÀÇ Áø·Î¸¦ °üÂû ÇÒ ¼ö ÀÖ´Â °Í.
unorganized ferment
¹«»ý È¿¸ð
untoward drug effect
¾à¹°ÀÇ ¹Ù¶÷Á÷ÇÏÁö ¾Ê´Â È¿°ú
¿ì¸®°¡ ¿øÇÏ´Â Ä¡·á ¸ñÀû¿¡ ºÎÇÕÇÏ´Â ¾à¸® ÀÛ¿ëÀÌ ¾Æ´Ï¶ó ÀÎü¿¡ ÇØ°¡µÇ´Â µ¶ ÀÛ¿ë ¶Ç´Â ºÎÀÛ¿ë.
waveguide effect
µµÆÄ°ü È¿°ú
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
invertase
(»ýÈ)ÀÚ´ç(ÀüÈ)È¿¼Ò
irregular
ºÒ±ÔÄ¢ÇÑ;º¯Ä¢ÀûÀÎ;°í¸£Áö ¸øÇÑ;°°Áö¾ÊÀº;°®ÃßÁö ¸øÇÑ;(±æµî)¿ïÅüºÒÅüÇÑ(ÇàÀ§µîÀÌ)ºÒ¹ýÀÇ;¹ÝÄ¢ÀÇ;¹«È¿ÀÇ;±ÔÀ²ÀÌ ¾ø´Â;³ÀâÇÑ;ºñÁ¤±Ôº´;ºñÁ¤±Ô±º;±Ô°Ý¿¡ ¸ÂÁö ¾Ê´Â »óǰ;2µîǰ;µî¿Üǰ
irritant
ÀÚ±ØÇÏ´Â;ÀڱؼºÀÇ;ÀÚ±ØÁ¦(¹°);¹«È¿ÈÇÏ´Â
irritate
Â¥Áõ³ª°Ô(ÃÊÁ¶ÇϰÔ)ÇÏ´Ù;ȳª°Ô ÇÏ´Ù;¾È´ÞÇϰÔÇÏ´Ù;ÀÚ±ØÇÏ´Ù;¿°ÁõÀ» ÀÏÀ¸Å°´Ù;¹«È¿·ÎÇÏ´Ù;½ÇÈ¿½ÃŰ´Ù
isozyme
(»ýÈ)µ¿Áú(µ¿À§)È¿¼Ò
joker
³ó´ãÇÏ´Â »ç¶÷;ÀÍ»ì²Û;(Ä«µå)Á¶Ä¿;(Á¤°ü,¹ý¾ÈÀÇ È¿·Â ±Ùº»ÀûÀ¸·Î ¾àÈ ½Ã۱â À§ÇØ ½½Â½ »ðÀÔÇÑ)»ç±â Á¶Ç×;»ç±â;Ã¥·«
juiced
...ÀÇ Áó(¾×ü)À» ÇÔÀ¯ÇÑ;ÃëÇÑ;¸¶¾àÀÌ È¿°ú°¡ ³ªÅ¸³
kallikrein
Ä®¸®Å©·¹ÀÎ(Ç÷Àå¿¡¼ Ű´ÑÀ» À¯¸®½ÃŰ´Â È¿¼Ò)
kinase
Ű³ª¾ÆÁ¦(È¿¼ÒÀÇ ÀÏÁ¾)
kludge
Ŭ·çÁö(ºÎÁ¶ÈÇÑ ±¸¼º ¿ä¼Ò·Î ÀÌ·ç¾îÁø ÄÄÇ»ÅÍ) ÀåÄ¡);¼ÒÇÁÆ®¿þ¾î»óÀÇ ±ÍÂúÀº ¹®Á¦¿¡ ´ëÇÑ È¿À²ÀûÀÎ ÇØ°á
lactase
¶ôŸ¾ÆÁ¦(À¯´ç ºÐÇØ È¿¼Ò)
lapsed
Áö³ª°£;¾ø¾îÁø;Ÿ¶ôÇÑ;½Å¾ÓÀ» ÀÒÀº;(°ü½À µîÀÌ)¼èÅðÇÑ;ÆóÁöµÈ;(±Ç¸®,Àç»êÀÌ)³²ÀÇ ¼ÕÀ¸·Î ³Ñ¾î°£;½ÇÈ¿ÇÑ
layering
(¸ð¾ç,»öüÀûÀÎ È¿°ú¸¦ ³ë·Á)²¸ÀÔ±â;(ÁöÇüÀÇ)´Üä½Ä
leaven
È¿¸ð;´©·è;the old ~ ±¸Æó
leaven
¹ßÈ¿½ÃŰ´Ù;¿µÇâÀ» ÁÖ´Ù
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½